XENE Xenon Pharmaceuticals Inc.

NASDAQ
$60.77

Xenon Pharmaceuticals Inc. (XENE) Institutional Ownership

What the institutions did with XENE last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
333
filed a 13F this quarter
Managers holding
311
+25 on the quarter
Buyers
172
47 opened new
Sellers
108
22 sold out entirely
Buyer share
61.4%
of managers who traded it
Breadth
+22.9
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
FMR LLC 9.6M 9.6%
BlackRock, Inc. 7.5M 7.4%
Avoro Capital Advisors LLC 5.8M 5.7%
Polar Capital Holdings Plc 4.6M 4.5%
Driehaus Capital Management LLC 4.4M 4.4%
Jupiter Topco LLC 4.2M 4.1%
PRICE T ROWE ASSOCIATES INC /MD/ 3.2M 3.2%
JPMORGAN CHASE & CO 2.6M 2.6%
Capital International Investors 2.4M 2.3%
T. Rowe Price Investment Management, Inc. 2.2M 2.1%
STATE STREET CORP 2.0M 1.9%
TWO SIGMA INVESTMENTS, LP 1.6M 1.6%
DEERFIELD MANAGEMENT COMPANY, L.P. 1.6M 1.6%
Affinity Asset Advisors, LLC 1.6M 1.6%
ALLIANCEBERNSTEIN L.P. 1.6M 1.5%
WESTFIELD CAPITAL MANAGEMENT CO LP 1.5M 1.5%
FRANKLIN RESOURCES INC 1.4M 1.4%
WELLINGTON MANAGEMENT GROUP LLP 1.4M 1.4%
CITADEL ADVISORS LLC 1.4M 1.4%
GEODE CAPITAL MANAGEMENT, LLC 1.4M 1.4%
Siren, L.L.C. 1.3M 1.3%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 1.3M 1.3%
Pictet Asset Management Holding SA 1.2M 1.2%
BRAIDWELL LP 1.1M 1.1%
Nuveen, LLC 993.1K 1.0%

Largest changes

Manager Action Previous Current Change
WELLINGTON MANAGEMENT GROUP LLP Reduced 4.8M 1.4M -3.4M
PRICE T ROWE ASSOCIATES INC /MD/ Increased 1.3M 3.2M +1.9M
BlackRock, Inc. Increased 5.6M 7.5M +1.9M
Holocene Advisors, LP Sold Out 1.5M 0 -1.5M
CITADEL ADVISORS LLC Reduced 2.7M 1.4M -1.3M
T. Rowe Price Investment Management, Inc. Increased 952.0K 2.2M +1.2M
FMR LLC Reduced 10.8M 9.6M -1.2M
JENNISON ASSOCIATES LLC Reduced 1.3M 208.1K -1.1M
TWO SIGMA INVESTMENTS, LP Increased 606.1K 1.6M +1.0M
Invesco Ltd. Increased 59.1K 903.5K +844.4K
Commodore Capital LP Sold Out 825.0K 0 -825.0K
Nuveen, LLC Increased 250.0K 993.1K +743.1K
JPMORGAN CHASE & CO Increased 1.9M 2.6M +693.8K
MARSHALL WACE, LLP New 0 689.3K +689.3K
PANAGORA ASSET MANAGEMENT INC New 0 664.0K +664.0K
Alyeska Investment Group, L.P. Reduced 1.3M 697.7K -601.8K
MPM BIOIMPACT LLC Sold Out 588.7K 0 -588.7K
Pictet Asset Management Holding SA Increased 679.7K 1.2M +508.0K
Caligan Partners LP Reduced 1.4M 889.9K -503.1K
Jones Hill Capital LP New 0 367.9K +367.9K
Capital International Investors Reduced 2.7M 2.4M -313.1K
Man Group plc New 0 310.6K +310.6K
Sofinnova Investments, Inc. Sold Out 305.2K 0 -305.2K
Fiera Capital Corp Reduced 709.5K 405.6K -303.9K
GEODE CAPITAL MANAGEMENT, LLC Increased 1.1M 1.4M +277.2K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.